Targeted niosomes protect the heart from doxorubicin-induced injury: evidence from oxidative stress, pyroptosis, and apoptosis pathways
{{output}}
Doxorubicin (DOX) is a frontline chemotherapeutic agent whose clinical utility is significantly limited by dose-dependent and often irreversible cardiotoxicity. Niosomal drug delivery systems, owing to their biocompatibility and tumour-targeting potential, oft... ...
